Pharmacology of P2X Receptors and Their Possible Therapeutic Potential in Obesity and Diabetes.

P2X receptors adenosine 5′-triphosphate diabetes drugs obesity

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
28 Sep 2024
Historique:
received: 08 08 2024
revised: 21 09 2024
accepted: 26 09 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 26 10 2024
Statut: epublish

Résumé

The role of P2X ionotropic receptors in the behavior of purinergic signaling on pathophysiological processes has been widely studied. In recent years, the important participation of P2X receptors in physiological and pathological processes, such as energy metabolism, characteristic inflammatory responses of the immune system, and nociceptive activity in response to pain stimuli, has been noted. Here, we explore the molecular characteristics of the P2X receptors and the use of the different agonist and antagonist agents recently described, focusing on their potential as new therapeutic targets in the treatment of diseases with emphasis on obesity, diabetes, and some of the complications derived from these pathologies.

Identifiants

pubmed: 39458933
pii: ph17101291
doi: 10.3390/ph17101291
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Auteurs

Guillermo A Cabral-García (GA)

Departamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes 20100, Mexico.

José R Cruz-Muñoz (JR)

Departamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes 20100, Mexico.

Eduardo E Valdez-Morales (EE)

Departamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes 20100, Mexico.
Consejo Nacional de Humanidades, Ciencias y Tecnologías (CONAHCyT), Ciudad de México 03940, Mexico.

Alma Barajas-Espinosa (A)

Escuela Superior de Huejutla, Universidad Autónoma del Estado de Hidalgo, Huejutla de Reyes 43000, Hidalgo, Mexico.

Andrómeda Liñán-Rico (A)

Consejo Nacional de Humanidades, Ciencias y Tecnologías (CONAHCyT), Ciudad de México 03940, Mexico.
Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Colima 28045, Mexico.

Raquel Guerrero-Alba (R)

Departamento de Fisiología y Farmacología, Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Aguascalientes 20100, Mexico.

Classifications MeSH